Immunotherapy combined with rh-endostatin improved clinical outcomes over ICIs plus chemotherapy for second-line treatment of advanced NSCLC

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览0
暂无评分
关键词
advanced nsclc,chemotherapy,icis,rh-endostatin,second-line
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要